Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OA TREAT trial of hydroxychloroquine in erosive-inflammatory hand osteoarthritis
2011-001689-16Phase 3Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Feb 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in hand osteoarthritis and erosive hand osteoarthritis (EHOA) comparing Hydroxychloroquine with Placebo (2 arms). Primary endpoints: AUSCAN pain at week 52 and AUSCAN hand disability at week 52. Started Feb 2013; status: completed.
02
Drugs
hydroxychloroquine
03
Conditions
hand osteoarthritiserosive hand osteoarthritis (EHOA)
Beyond the preview
Go deeper on 2011-001689-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001689-16.